RxDoctor Payments Data

Adam Edelstein, MD

Adult Reconstructive Orthopaedic Surgery · Chicago, ILNPI 1013279082

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $17,912 of the $26,059 with a category attached, or 68.7%. 7 manufacturers reported payments, led by Medical Device Business Services, Inc. at 42.2% of the total. Reporting peaked in 2024 at $9,803 and has fallen 67.2% since, to $3,219 in 2025.

$26,059in general payments, 2019–2025

Across 72 payments — averaging $361.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$11K
  • Omnilife Science, Inc$8K
  • Depuy Synthes Products, Inc.$3K
  • Zimmer Biomet$2K
  • Stryker$1K
  • Medacta USA, Inc.$1K
  • plus $262 from 1 others
$12,550in research payments, 2019–2025

Across 1 payment — averaging $12,550 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medacta USA, Inc.$13K

What the payments were for

  • Consulting fees$17,91269%
  • Travel & lodging$4,20616%
  • Food & beverage$3,94015%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,059 in reported general payments places this provider in the 70th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.

See all adult reconstructive orthopaedic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$332,666
Medicare patients
540
Services billed
3,341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium22$611
Mupirocin92$599
Meloxicam23$68
Amoxicillin28$54

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →